These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3137644)

  • 61. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.
    Santoso JT; Lucci JA; Coleman RL; Schafer I; Hannigan EV
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):13-8. PubMed ID: 12719883
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of oral and intravenous hydration and diuretic, choice for protecting cisplatin induced nephrotoxicity.
    Dana R; Kachhwaha VS
    Indian J Cancer; 1996 Dec; 33(4):168-70. PubMed ID: 9254992
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevention of cisplatin-induced nephrotoxicosis in dogs, using hypertonic saline solution as the vehicle of administration.
    Forrester SD; Fallin EA; Saunders GK; Kenny JE
    Am J Vet Res; 1993 Dec; 54(12):2175-8. PubMed ID: 8116956
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cisplatin: a review of clinical applications and renal toxicity.
    Sleijfer DT; Meijer S; Mulder NH
    Pharm Weekbl Sci; 1985 Dec; 7(6):237-44. PubMed ID: 3909096
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cisplatin: a review of toxicities and therapeutic applications.
    Barabas K; Milner R; Lurie D; Adin C
    Vet Comp Oncol; 2008 Mar; 6(1):1-18. PubMed ID: 19178659
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cisplatin update.
    Muggia FM
    Semin Oncol; 1991 Feb; 18(1 Suppl 3):1-4. PubMed ID: 2003223
    [No Abstract]   [Full Text] [Related]  

  • 68. [Hydration of patients treated with cisplatin: practical investigation and establishment of a protocol].
    Saint-Lorant G; Madelaine J; Galais MP; Thierry L; Chédru-Legros V
    Therapie; 2005; 60(5):499-505. PubMed ID: 16433016
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Administration of high doses of cisplatin in 20-minute infusions].
    Cirera L; Gay M; Tomé T; Martí M; Huguet J; Plá R
    Rev Clin Esp; 1988 Mar; 182(4):192-5. PubMed ID: 3137644
    [No Abstract]   [Full Text] [Related]  

  • 70. Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin.
    Cornelison TL; Reed E
    Gynecol Oncol; 1993 Aug; 50(2):147-58. PubMed ID: 8375728
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Cisplatin in the treatment of malignant tumors].
    Wang QL
    Zhonghua Zhong Liu Za Zhi; 1983 Nov; 5(6):461-4. PubMed ID: 6426911
    [No Abstract]   [Full Text] [Related]  

  • 72. [Low-volume infusion therapy with hyperosmolar sodium chloride solutions in the treatment of acute massive blood loss].
    Tsybuliak GN; Chechetkin AV
    Vestn Khir Im I I Grek; 1999; 158(2):73-6. PubMed ID: 10368901
    [No Abstract]   [Full Text] [Related]  

  • 73. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
    Launay-Vacher V; Rey JB; Isnard-Bagnis C; Deray G; Daouphars M;
    Cancer Chemother Pharmacol; 2008 May; 61(6):903-9. PubMed ID: 18317762
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.